Biochemistry laboratory shift based on common terminology criteria in patients with advanced basal cell carcinoma receiving sonidegib 200 mg daily: Results from the 42-month BOLT study. (2023). SKIN The Journal of Cutaneous Medicine, 7(2), s181. https://doi.org/10.25251/skin.7.supp.181